Abbott India Ltd. — Regulatory Filings 2021

Jan 29, 2021

==> picture [105 x 103] intentionally omitted <==

Abbott India Limited Registered Office: Tel: (91-22) 5046 1000/2000 Godrej BKC, Plot C-68,”G”Block, 3, Corporate Park, Fax : (91-22) 5016 9400 15-16th Floor, Bandra-Kurla Complex, Sion Trombay Road, E-mail : webmasterindia@abbott.com Near MCA Club, Bandra (E), Mumbai - 400 071.India Website : www.abbott.co.in Mumbai - 400 051. India CIN: L24239MH1944PLC007330

BSE Limited Corporate Relationship Department Phiroze Jeejeebhoy Towers Dalal Street Mumbai 400 001

January 29, 2021

Scrip Code: 500488

Dear Sir/Madam,

Sub: Intimation under Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015

In terms of Regulation 29 (1) (a) of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby inform you that a Meeting of the Board of Directors of the Company is scheduled to be held on Tuesday, February 9, 2021 interalia, to consider and approve the text of Unaudited Financial Results of the Company for the third quarter and nine months ended on December 31, 2020.

Further please note that in terms of Abbott India Code of Internal Procedures and Conduct for Regulating, Monitoring and Reporting of Trading by Insiders and in accordance with the provisions of the Securities and Exchange Board of India (Prohibition of Insider Trading) (Amendment) Regulations, 2019, the Trading Window of the Company remains closed from Thursday, December 31, 2020 to Thursday, February 11, 2021 (both days inclusive).

Kindly acknowledge the receipt of the same.

Thank you.

Yours faithfully,

Abbott India Limited

==> picture [60 x 55] intentionally omitted <==

Krupa Anandpara Company Secretary Membership No.: ACS 16536